3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
14
Prostatic Neoplasms
12
Multiple Myeloma
8
Neoplasm Metastasis
6
Osteoporosis
4
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Lung Neoplasms
2
Kidney Neoplasms
2
Bone Diseases
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Osteonecrosis
1
Oligodendroglioma
1
Neovascularization, Pathologic
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Micrometastasis
1
Nasopharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Lymphoma
1
Interventions
Paclitaxel
5
Carboplatin
5
Docetaxel
4
Cisplatin
4
Bevacizumab
4
Taxes
3
Drug Therapy
3
Gemcitabine
2
Fluorodeoxyglucose F18
2
Cetuximab
2
saracatinib
1
endostar protein
1
cediranib
1
aflutinib
1
Zoledronic Acid
1
X-Rays
1
Vinorelbine
1
Thoracic Surgery, Video-Assisted
1
Spectrum Analysis
1
Silver Nitrate
1
Saline Solution
1
Radiotherapy, Conformal
1
Radiation
1
Pleurodesis
1
Pemetrexed
1
Nivolumab
1
Naproxen
1
N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea
1
Morphine
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pleural Effusion, Malignant
×
Zoledronic Acid
×
Clear all
NCT01004510
2012-12-04
ZAP
Rochester General Hospital
Phase 2
Terminated
3 enrolled
5 charts